Prostatitis - Clinical trials 

  • Clinical trials

Clinical trials for Prostatitis

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Prostatitis. For all clinical trials, go to clinical trials search

This list shows clinical trials for Prostatitis

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Prostatitis
Title Recruitment status Location
A randomised placebo controlled study of Tamsulosin, Voltarol and the combination in types IIIa and IIIb prostatitis using the newly developed and validated National Institutes of Health (NIH) symptom score Not recruiting United Kingdom
Efficacy Study of Tamsulosin and Tolterodine Treatment for Chronic Prostatitis Recruiting China
Development of early diaogostic kit for prostate cancer Recruiting China
Botulinum Toxin Type A for the Treatment of Male Chronic Pelvic Pain Syndrome Recruiting Switzerland
Laparoscopic Prostatectomy for Chronic Prostatitis Recruiting United States
Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) Recruiting United States
A Clinical Study to Investigate the Efficacy, Safety and Pharmacokinetics of ASP3652 in Patients With Chronic Abacterial Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS) Recruiting Czech Republic
A Clinical Study to Investigate the Efficacy, Safety and Pharmacokinetics of ASP3652 in Patients With Chronic Abacterial Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS) Recruiting Germany
A Clinical Study to Investigate the Efficacy, Safety and Pharmacokinetics of ASP3652 in Patients With Chronic Abacterial Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS) Recruiting Italy
A Clinical Study to Investigate the Efficacy, Safety and Pharmacokinetics of ASP3652 in Patients With Chronic Abacterial Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS) Recruiting Latvia
  • Link to Directgov – public services all in one place
  • The Information Standard - Certified member